RxSight, Inc. Interest and Other Income
RxSight, Inc. (RXST) reported Interest and Other Income of $1.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-05
- RxSight, Inc. interest and other income for the quarter ending 2026-06-30 was $1.76M, a 21.74% decline year-over-year.
- RxSight, Inc. interest and other income for the quarter ending 2026-03-31 was $1.95M, a 22.09% decline year-over-year.
- RxSight, Inc. interest and other income for the quarter ending 2025-12-31 was $2.19M, a 18.91% decline year-over-year.
- RxSight, Inc. interest and other income for the quarter ending 2025-09-30 was $2.38M, a 18.24% decline year-over-year.
- RxSight, Inc. interest and other income for fiscal 2025 was $9.33M, a 1.50% decline from fiscal 2024.
- RxSight, Inc. interest and other income for fiscal 2024 was $9.47M, a 44.11% increase from fiscal 2023.
- RxSight, Inc. interest and other income for fiscal 2023 was $6.57M, a 333.36% increase from fiscal 2022.
- RxSight, Inc. interest and other income for fiscal 2022 was $1.52M, a 2709.26% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.76M 10-Q · filed 2026-08-05 | $3.72M 10-Q · filed 2026-08-05 | $5.91M derived: sum of 3 quarters · filed 2026-08-05 | $8.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.95M 10-Q · filed 2026-05-06 | $4.15M derived: sum of 2 quarters · filed 2026-05-06 | $6.53M derived: sum of 3 quarters · filed 2026-05-06 | $8.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.57M derived: sum of 2 quarters · filed 2026-02-25 | $6.83M derived: sum of 3 quarters · filed 2026-08-05 | $9.33M 10-K · filed 2026-02-25 |
| 2025-09-30 | $2.38M 10-Q · filed 2025-11-05 | $4.63M derived: sum of 2 quarters · filed 2026-08-05 | $7.14M 10-Q · filed 2025-11-05 | $9.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.25M 10-Q · filed 2026-08-05 | $4.76M 10-Q · filed 2026-08-05 | $7.47M derived: sum of 3 quarters · filed 2026-08-05 | $10.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.51M 10-Q · filed 2026-05-06 | $5.21M derived: sum of 2 quarters · filed 2026-05-06 | $8.12M derived: sum of 3 quarters · filed 2026-05-06 | $10.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.61M derived: sum of 2 quarters · filed 2026-02-25 | $7.89M derived: sum of 3 quarters · filed 2026-02-25 | $9.47M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.91M 10-Q · filed 2025-11-05 | $5.18M derived: sum of 2 quarters · filed 2025-11-05 | $6.77M 10-Q · filed 2025-11-05 | $8.43M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $2.28M 10-Q · filed 2025-08-07 | $3.86M 10-Q · filed 2025-08-07 | $5.52M derived: sum of 3 quarters · filed 2026-02-25 | $7.27M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.58M 10-Q · filed 2025-05-07 | $3.25M derived: sum of 2 quarters · filed 2026-02-25 | $4.99M derived: sum of 3 quarters · filed 2026-02-25 | $6.77M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.41M derived: sum of 2 quarters · filed 2026-02-25 | $5.18M derived: sum of 3 quarters · filed 2026-02-25 | $6.57M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.75M 10-Q · filed 2024-11-07 | $3.52M derived: sum of 2 quarters · filed 2024-11-07 | $4.91M 10-Q · filed 2024-11-07 | $5.75M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.78M 10-Q · filed 2024-08-05 | $3.17M 10-Q · filed 2024-08-05 | $4.00M derived: sum of 3 quarters · filed 2025-02-25 | $4.44M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.39M 10-Q · filed 2024-05-06 | $2.23M derived: sum of 2 quarters · filed 2025-02-25 | $2.67M derived: sum of 3 quarters · filed 2025-02-25 | $2.86M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.27M derived: sum of 2 quarters · filed 2025-02-25 | $1.47M derived: sum of 3 quarters · filed 2025-02-25 | $1.52M 10-K · filed 2025-02-25 |
| 2022-09-30 | $439.00K 10-Q · filed 2023-11-09 | $635.00K derived: sum of 2 quarters · filed 2023-11-09 | $681.00K 10-Q · filed 2023-11-09 | $691.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $196.00K 10-Q · filed 2023-08-07 | $242.00K 10-Q · filed 2023-08-07 | $252.00K derived: sum of 3 quarters · filed 2023-08-07 | $263.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-09 | $56.00K derived: sum of 2 quarters · filed 2023-05-09 | $67.00K derived: sum of 3 quarters · filed 2023-05-09 | $82.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $21.00K derived: sum of 2 quarters · filed 2023-03-06 | $36.00K derived: sum of 3 quarters · filed 2023-03-06 | $54.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $11.00K 10-Q · filed 2022-11-07 | $26.00K derived: sum of 2 quarters · filed 2022-11-07 | $44.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $15.00K 10-Q · filed 2022-08-08 | $32.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $63.00K 10-Q · filed 2021-11-10 | $210.00K derived: sum of 2 quarters · filed 2021-11-10 | $522.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $147.00K 10-Q · filed 2021-09-09 | $459.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |